E3A Healthcare has been selected for the Hong Kong Startup Incubation Program.

The Hong Kong Science and Technology Park is a statutory body established by the Hong Kong Special Administrative Region Government in 2001. It provides support for companies in key technology fields such as biomedicine, electronics, green technology, information and communication technology, materials and precision engineering, including scientific research facilities, infrastructure Construction, service and planning, assisting technology companies to incubate ideas, innovate and develop.

As the largest high-tech R&D and business incubation base in Hong Kong, the Hong Kong Science and Technology Park has many inherent advantages in incubating and accelerating start-ups, including an international exchange platform and cooperation opportunities with industry leaders. Today, the number of technology and start-up companies has increased from 700 to 1,000 in the past five years (2016-2021), with more than 17,000 innovation and technology practitioners, attracting many well-known domestic and foreign scientific research institutions and universities to set up experiments room.

This time, Yishan Medical was successfully selected for the three-year INCUBATION PROGRAM of the Hong Kong Science and Technology Park. This program provides comprehensive support to help technology start-ups launch their scientific research results into the market and expand their business, including scientific research support and mentors. Mentoring and investor matching, etc.

So far, as many as 850 incubation companies have successfully graduated from the Innovation and Technology Incubation Program, 80% of which are still in operation, and four of them have applied for listing in Hong Kong. These companies are currently applying for intellectual property rights for more than 1,000 research and development achievements, and have won more than 630 awards so far.

As a Chinese and Hong Kong medical science and technology innovation enterprise, Yishan Medical has personally felt the rapid development of the Hong Kong-Macao Greater Bay Area in the field of medical science and technology innovation in recent years, and also benefited from the good science and technology innovation environment and the support of strong industrial resources. At present, Yishan medical product line has fully covered the whole cycle of pregnancy, childbirth and childbearing of women. The first innovative self-developed product - neonatal transcutaneous jaundice instrument has also been successfully launched in the domestic market, and has received good market feedback and user recognition. We always adhere to our original intention and are committed to providing higher quality medical devices and services for mothers and babies around the world through our scientific and technological innovation and research and development.

This time we have successfully joined the innovation and technology incubation program of the Hong Kong Science and Technology Park. We will have more opportunities to communicate with international platforms, cooperate with industry leaders, world-class equipment, and financial assistance. Step into the global market.

In the future, Yishan Medical will continue to deeply cultivate the medical device industry, unswervingly promote the innovation and development of domestic medical equipment through independent research and development and production, so as to accelerate the completion of "import substitution" of domestic medical equipment. Follow the important instructions made by General Secretary Xi Jinping when he visited Hong Kong to inspect the Hong Kong Science and Technology Park in June this year-"Give full play to Hong Kong's own advantages, gather global innovation resources, and perfectly match the inland cities of the Guangdong-Hong Kong-Macao Greater Bay Area, strengthen the collaboration of industry-university-research innovation, and focus on Build a global technological innovation highland". Committed to providing "IoT+SaaS" full-cycle smart medical solutions for mothers and babies for thousands of families around the world.

Previous
Previous

E3A Healthcare wins 2nd place at the Grand Finals of the 2022 Global Digital Economy Innovation Competition.

Next
Next

CGTN: Hong Kong entrepreneurs are confident about the future.